Sunday Herald: pinion & Debate: pinion & Debate
The News Review:
- Sunday Herald: pinion & Debate: pinion & Debate
- New Data Demonstrate Efficacy f Aerius(R) (Desloratadine) In…
- Microenvironment A Main Driver f Aggressive Multi-lineage Leukemia…
- Hi-dose Immunosuppressant Drug Reverses Multiple Sclerosis Symptoms…
- Triangle Capital supplies millions to Detroit firm
Sunday Herald: pinion & Debate: pinion & Debate
Sunday Herald – Jun 11, 2008
Yet in medical terms it is relatively new with advances made year-on-year as new research yields new success in the fight against diseases such as leukaemia. Since the early 1960s when two Canadian scientists Ernest McCulloch and James Till first began looking at the stem cells medical research has never doubted their potential to make a hugely positive contribution to the treatment of human diseases including cancer Parkinson’s disease spinal cord injuries and many others. Certainties don’t exist in clinical research as the long fight to discover cures and new therapies for HIV and Aids has shown. But it is a certainty that if stem-cell research simply halts or backs off from new approaches then nothing of value will be discovered. Writing in this newspaper and speaking later today from the pulpit of a Roman Catholic church in Edinburgh Cardinal Keith ‘Brien states that claim after claim has been made for research that involves the use of stem cells taken from human embryos and that after a decade of promised cures and treatments not one new treatment or therapy has arrived. Like any prominent church leader the cardinal is entitled to his opinion an opinion that in the case of Roman Catholics in Scotland is expected to be followed without question as part of the church’s wider teaching. advertisementIn the case of Catholic MPs the archbishop expects to see them vote against the government’s Human Fertilisation and Embryology Bill which allows on the archbishop’s interpretation of the science “the creation of hybrid human-animal embryos” a procedure which involves a “monstrous attack on human rights human dignity and human life”… But by not making it clear if a three-line whip is going to be imposed the PM has created a heated forum where the views of Cardinal ‘Brien and others are given a public currency rather than being confined to the teachings within their own church. Brown should quickly make it clear there will be no three-line whip and that Labour MPs will be allowed to vote as their conscience directs. If the bill does not pass this field of clinical research and the benefits it may bring will not be lost. It will be conducted in another country – and when the medical advances do come which one of us will turn them away or deny them to our children? Share this story on:.
New Data Demonstrate Efficacy f Aerius(R) (Desloratadine) In…
Medical News Today – Medical News Today (press release) – Jun 11, 2008
” About ACCEPTThe ACCEPT (AERIUS Control: Clinical and Evaluative Profile of Treatment) clinical trials consisted of two multi-national prospective randomized placebo-controlled studies of AERIUS 5 mg in patients 12 years of age or older with ARIA-defined AR. The trials evaluated the efficacy impact on quality of life productivity and pharmacoeconomics in patients with IAR in one study and also evaluated PER in an additional study. Studies were conducted in collaboration with the Global Allergy and Asthma European Network (GA2LEN) a clinical research network of leading European research centers through an unrestricted grant from Schering-Plough. Participating countries in the ACCEPT trials included Canada France Germany Italy Spain Denmark Sweden Belgium the Netherlands Hungary Greece Finland Portugal Turkey and Russia. The IAR ACCEPT trial assessed the effect of AERIUS 5 mg versus placebo administered once daily for 15 days. A total of 547 patients were randomized with 276 patients receiving AERIUS and 271 receiving placebo. All patients were required to have ARIA-defined IAR for at least two years that was symptomatic at baseline and patients also had to demonstrate a positive skin-prick test to at least one relevant allergen preferably using the GA²LEN allergen panel.
Microenvironment A Main Driver f Aggressive Multi-lineage Leukemia…
Science Daily – Science Daily (press release) – Jun 11, 2008
Cancelas Yi Gu Michael Jansen and Jorge F. Funding support came from the National Institutes of Health (including the General Clinical Research Centers Program at the National Center for Research Resources) a grant from the University of Cincinnati Cancer Center the American Society of Hematology and a grant from the Minsterio de Sanidad. Adapted from materials provided by. cincinnatichildrens.
Hi-dose Immunosuppressant Drug Reverses Multiple Sclerosis Symptoms…
Science Daily – Science Daily (press release) – Jun 11, 2008
This research was supported by the General Clinical Research Center of the Johns Hopkins School of Medicine a National Multiple Sclerosis Society grant philanthropic support from Mr. Alvin Myerbrg and the Johns Hopkins Project RESTRE. Journal reference:Krishnan et al. Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis.
Triangle Capital supplies millions to Detroit firm
News & bserver – Jun 11, 2008
Accountants ne an accounting and financial recruiting firm is opening an office in Raleigh. Brad Barbour will manage the office. PharmaLinkFHI in Durham has acquired Matrix Contract Research a British clinical research organization and clinical staffing company. Nigel Trim Matrix’s president will head up European operations for the combined company. Chatham Hill Winery has moved to a new facility at 3800 Gateway Centre Blvd.
Written by admin on June 11th, 2008 with
no comments.
Read more articles on News.